No Data
No Data
Tonix Pharmaceuticals 4Q Loss/Shr $9.77 >TNXP
Express News | Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
12 Health Care Stocks Moving In Tuesday's Intraday Session
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
ElToroToco : I pray to God yes